Li Lin

Yisaipu® Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation

Yuanqiong Wang, Huji Xu, Ling Zhou, 2021, Frontiers in Pharmacology.

Development and validation of a leukocyte‐associated immunoglobulin‐like receptor‐1 prognostic signature for lower‐grade gliomas

K. Huang, Lei Wu, Xin-gen Zhu, 2022, Cancer medicine.

Ferroptosis in tumor immunity and therapy

Maohui Luo, Miao-jing Wu, K. Huang, 2022, Journal of cellular and molecular medicine.

Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients

Miao-jing Wu, K. Huang, M. Ye, 2021, Frontiers in Oncology.

Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy

Maohui Luo, K. Huang, Lei Wu, 2023, Journal of Experimental & Clinical Cancer Research.

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma

Maohui Luo, K. Huang, Lei Wu, 2021, Frontiers in Oncology.